Your browser doesn't support javascript.
loading
ONZIN Upregulation by Mutant p53 Contributes to Osteosarcoma Metastasis Through the CXCL5-MAPK Signaling Pathway.
Zhang, Yanqin; Hu, Qianghua; Li, Guixin; Li, Lili; Liang, Shoulei; Zhang, Yun; Liu, Jiayong; Fan, Zhengfu; Li, Lin; Zhou, Bingzheng; Ruan, Yongxin; Yang, Xueli; Chen, She'an; Mu, Tianyang; Wang, Guowen; Xiong, Shunbin.
Afiliación
  • Zhang Y; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Hu Q; National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center of Cancer, Tianjin, China.
  • Li G; Department of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Li L; Department of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Liang S; Department of Laboratory Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Zhang Y; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Liu J; National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center of Cancer, Tianjin, China.
  • Fan Z; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Li L; National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center of Cancer, Tianjin, China.
  • Zhou B; College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, USA.
  • Ruan Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Bone and Soft Tissue Tumor, Peking University Cancer Hospital & Institute, Beijing, China.
  • Yang X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Bone and Soft Tissue Tumor, Peking University Cancer Hospital & Institute, Beijing, China.
  • Chen S; Department of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Mu T; Department of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Wang G; Department of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Xiong S; Department of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Cell Physiol Biochem ; 48(3): 1099-1111, 2018.
Article en En | MEDLINE | ID: mdl-30041188
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas / Proteína p53 Supresora de Tumor / Proteínas Quinasas Activadas por Mitógenos / Quimiocina CXCL5 Límite: Adult / Animals / Female / Humans / Male Idioma: En Revista: Cell Physiol Biochem Asunto de la revista: BIOQUIMICA / FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas / Proteína p53 Supresora de Tumor / Proteínas Quinasas Activadas por Mitógenos / Quimiocina CXCL5 Límite: Adult / Animals / Female / Humans / Male Idioma: En Revista: Cell Physiol Biochem Asunto de la revista: BIOQUIMICA / FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China